Medical device marketing for hospital buyers

A medical device marketing agency helps a device company reach the clinicians, supply chain staff and committees behind a hospital purchase, in claims its regulatory team has approved. openFDA lists 3,198 510(k) submissions found substantially equivalent in 2025. Growigami runs outreach, sales assets, search and event follow-up as processes from $1,999 a month.

What does a medical device marketing agency do?

It gets a device in front of the people who decide on a purchase, and gives each of them a reason to say yes. The five agency pages we read for this search describe much the same work:

• Positioning and messaging: messaging that makes sense “in both the boardroom and the OR,” in Icovy’s words.
• Launch and commercialization: the plan and material for a new device or a new market.
• Content: writing for physicians, patients and procurement teams.
• Digital: SEO, paid search, email and social.
• Sales enablement and events: collateral for reps and trade show work.

None of the five cites a specific FDA rule or says who approves a claim. Icovy says it “ensures” marketing is compliant, and Aha Media Group offers help “if compliance reviews often push back timelines.”

How do you market a medical device to hospitals?

To several people at once. Elevation B2B’s page names three audiences for device marketing: hospital administrators, healthcare providers and purchasing committees. IQVIA’s 2022 white paper on value analysis committees, based on a survey of 42 members, describes them as the groups that decide which devices come into their hospital.

Each of those people reads different material. A clinician reads a clinical summary, and a committee member reads a one-pager on evidence and cost. Marketing that writes one message for the whole account speaks to one of them.

Does account-based marketing fit medical devices?

It fits the way hospitals buy: a defined list of health systems and the people inside each one. Our Outbound process researches 500 target accounts a month and finds a reason each one would talk now. It writes a message for each contact by email and LinkedIn, and replies reach your sales team the same day.

Your seller approves each week’s messages before they go out. Whether your regulatory lead also reads every message, or signs off the claims the messages draw on, is your company’s choice.

What does a medical device marketing agency cost in 2026?

On 5 November 2026 we read five medtech agency pages from the results for this search and Healthcare Success’s guide to agency pricing models. None posts a price. The table uses our recheck of 12 B2B marketing firms on their own pages for the rest.

Option	Price	Terms	Source
Medtech agencies we read (Icovy, Aha Media Group, Elevation B2B, ParkerWhite, Podymos)	Not posted	Not posted	Their own pages, 5 November 2026
B2B marketing firms that publish a price, in dollars	From $5,000 a month	3 to 12 months, or 3 months’ notice, where published	Our recheck of 12 firms, 4 November 2026
B2B marketing firm, UK	From £3,500 a month plus project fees	3 months’ notice, or 6 to 12 month commitments	Our recheck of 12 firms, 4 November 2026
In-house marketing specialist	$78,760 a year, median pay	A permanent hire	BLS, market research analysts and marketing specialists, May 2025
Growigami, one process	From $1,999 a month	Minimum three months, then 30 days' notice	Our price list
Growigami, one process with a monthly CRO review	From $3,498 a month	Minimum three months, then 30 days' notice	Our price list

Of the 12 B2B marketing firms we compared in November 2026, six publish a price. A process costs $500 more in its first month while we build it, and your first build is on us this month. Three months of one process, the minimum term, come to $5,997 in all, because your first build is on us this month.

Which FDA and FTC rules apply to medical device marketing?

The rules depend on the device’s class and clearance or approval, and on whether it is a restricted device. Your regulatory lead and counsel decide what your company can say, and none of this is regulatory or legal advice. These are federal rules that device advertising is read against:

• Intended use. Under 21 CFR 801.4, a device’s intended use is the objective intent of the people legally responsible for its labeling. That intent can be shown by labeling claims, advertising matter, or oral or written statements by them or their representatives.
• Clearance is not approval. 21 CFR 807.97 says a 510(k) substantial equivalence determination does not denote official approval, and any representation that creates that impression is misleading and constitutes misbranding.
• Investigational devices. 21 CFR 812.7 bars a sponsor, or anyone acting for it, from promoting or test marketing an investigational device until FDA approves it for commercial distribution. It also bars representing the device as safe or effective for the purposes under investigation.
• Restricted devices. The FD&C Act treats a restricted device as misbranded if its advertising is false or misleading in any particular (21 U.S.C. 352(q)). Its ads and other descriptive printed matter must carry the device’s established name and a brief statement of intended uses and relevant warnings, precautions, side effects and contraindications (352(r)).
• FTC. The FTC Act makes it unlawful to disseminate a false advertisement to induce the purchase of devices (15 U.S.C. 52). An ad is false if it is misleading in a material respect, including by failing to reveal material facts (15 U.S.C. 55). The FTC’s Health Products Compliance Guidance (December 2022) asks for “competent and reliable scientific evidence” behind health benefit and safety claims.

Growigami drafts every page, email and one-pager from your labeling and approved claims, and our team checks outreach and pages before they reach you. Nothing goes out until the reviewer you name approves it. That can be your regulatory lead on every piece, or your sellers on each week’s messages, drawing only on claims your regulatory lead has approved. Your company decides which, and we hold no regulatory or compliance certification.

What Growigami runs for a medical device company

Each week, AI agents research target accounts and draft outreach, pages and sales material from your labeling, and our team checks the outreach and pages before they reach you. Your CRO, a growth lead who has run sales and marketing teams, builds each process with your marketing lead and proves it works before the agents run it. The reviewers you name approve the drafts before anything goes out, and your reps take the replies.

Find the contactHubSpot · VP Operations or QA lead

Draft the emailAgent · In Marcus’s voice

Done

Copy checkEvery claim has a source

Passed

Marcus sends each oneGmail · Head of Sales

You start with one process:

• Outbound (Pipeline): 500 target accounts researched a month, such as health systems, surgery centers or distributors. Each contact gets a message by email and LinkedIn, and replies reach your sales team the same day.
• Sales assets (Paid and creative): two assets a month. A case study or deck counts as one, and two one-pagers count as one, such as a value analysis summary and a procurement sheet.
• Events (Pipeline): booth materials and invites for up to three shows a month. We invite the accounts you want to meet, and each badge scan gets a follow-up written for that conversation.
• Deal follow-up: a brief before each sales call and a recap drafted after it, for up to 60 calls a month. Deals that went quiet get a new reason to talk.
• Search (Search): pages on the questions clinicians and buyers ask, drafted from your labeling. 200 pages a month at the base size, or 500 at the larger size for $1,499 more.

A review with your CRO is optional, at $1,499 a month for monthly sessions or $2,999 for weekly ones.

When a medtech specialist or an in-house team fits better

• You need a launch built from scratch. Icovy sells commercialization strategy, brand development and launch support for regulated health products, and ParkerWhite sells digital marketing and branding to device companies from the San Diego area.
• You market to patients. Aha Media Group writes direct-to-consumer content for patients alongside content for physicians and procurement teams. Our processes are built for hospital and distributor buyers.
• You need medical animation or video of a procedure. Icovy lists medical animations and video production among its services. Our Video process works from a short call or your product screens.
• You have a regulatory-trained marketer on staff. An in-house hire knows your claims history and your reviewers. The BLS puts median pay for market research analysts and marketing specialists at $78,760 a year (May 2025).

Component and contract manufacturers that sell to device engineers fit our manufacturing marketing page, and software companies outside healthcare fit tech marketing. For freight and 3PL companies, see logistics marketing.

Reworld: $250M+ in pipeline at a waste-to-energy firm

Reworld is a $3 billion waste-to-energy operator with four distinct buyer segments. Its CRM was messy, and its sales team chased leads nobody had qualified. We built a profile for each segment, so each campaign spoke to one buyer, and cleaned the CRM so marketing and sales saw one pipeline. Its pipeline, the deal value sales can work, reached $250M+, and it logged 600+ MQLs in four months (Reworld story).

A hospital account has its own segments: the clinician, the committee and procurement. Reworld sells waste services, and its result says nothing about pipeline for your device.

Talk to sales. Give us read access to your CRM, and within a week we show you the first process we would build and what it would produce.